Arkolith/Insider Trading/CALA

CALA Insider Trading

CALA · full profile →Last filing Apr 17, 2023
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

67 shown
DateInsiderRoleActionSharesPriceValue
Apr 17, 2023Takeda Ventures, Inc.10% OwnerOther(J)1.0M——
Jan 27, 2023Pakianathan DeepikaDirectorSell(S)120K$0.39$47K
Jan 27, 2023Pakianathan DeepikaDirectorSell(S)1K$0.39$457
Jan 23, 2023Molineaux ChristopherSR. VP, DEVELOPMENTTax withholding(F)217$0.45$98
Jan 23, 2023Wong StephanieSee RemarksTax withholding(F)317$0.45$143
Jan 23, 2023Molineaux SusanPRESIDENT & CEO, DirectorTax withholding(F)526$0.45$237
Jan 23, 2023Kuriakose EmilCHIEF MEDICAL OFFICERTax withholding(F)79$0.45$36
Jan 23, 2023Sjogren EricSR. VP, DRUG DISCOVERYTax withholding(F)279$0.45$126
Jul 1, 2022Takeda Pharmaceutical Co Ltd10% OwnerOther(J)1.0M—$0
Jul 1, 2022Takeda Pharmaceutical Co Ltd10% OwnerOther(J)1.0M—$0
Jun 1, 2022Orford KeithDirectorGrant(A)20K—$0
Jun 1, 2022Wolff Henry WardDirectorGrant(A)20K—$0
Jun 1, 2022Wise BlakeDirectorGrant(A)20K—$0
Jun 1, 2022Garland J. ScottDirectorGrant(A)20K—$0
Jun 1, 2022Agarwal SunilDirectorGrant(A)20K—$0
Jun 1, 2022Jones SuzyDirectorGrant(A)20K—$0
Jun 1, 2022Pakianathan DeepikaDirectorGrant(A)20K—$0
Jan 25, 2022Kuriakose EmilCHIEF MEDICAL OFFICERGrant(A)215K—$0
Jan 25, 2022Orford KeithDirectorGrant(A)40K—$0
Jan 25, 2022Molineaux ChristopherSR. VP, DEVELOPMENTGrant(A)165K—$0
Jan 25, 2022Parlati FrancescoSR. VP, RESEARCHGrant(A)165K—$0
Jan 25, 2022Sjogren EricSR. VP, DRUG DISCOVERYGrant(A)165K—$0
Jan 25, 2022Ray SumitaSee RemarksGrant(A)165K—$0
Jan 25, 2022Wong StephanieSee RemarksGrant(A)215K—$0
Jan 25, 2022Molineaux SusanPRESIDENT & CEO, DirectorGrant(A)597K—$0
Jan 21, 2022Kuriakose EmilCHIEF MEDICAL OFFICERTax withholding(F)666$0.49$326
Jan 21, 2022Sjogren EricSR. VP, DRUG DISCOVERYTax withholding(F)5K$0.49$2K
Jan 21, 2022Wong StephanieSee RemarksTax withholding(F)6K$0.49$3K
Jan 21, 2022Parlati FrancescoSR. VP, RESEARCHTax withholding(F)5K$0.49$2K
Jan 4, 2022Wong StephanieSee RemarksTax withholding(F)18K$0.66$12K
Jan 4, 2022Sjogren EricSR. VP, DRUG DISCOVERYTax withholding(F)18K$0.66$12K
Jan 4, 2022Kuriakose EmilCHIEF MEDICAL OFFICERTax withholding(F)4K$0.66$3K
Jan 4, 2022Parlati FrancescoSR. VP, RESEARCHTax withholding(F)18K$0.66$12K
Nov 11, 2021Orford KeithDirectorSell(S)48K$0.88$42K
Nov 10, 2021Orford KeithDirectorSell(S)30K$0.86$26K
Nov 10, 2021Molineaux SusanPRESIDENT & CEO, DirectorBuy(P)100K$0.85$85K
Nov 10, 2021Drachman Jonathan GDirectorBuy(P)200K$0.86$172K
Nov 10, 2021Molineaux ChristopherSR. VP, DEVELOPMENTBuy(P)100K$0.85$85K
Nov 9, 2021Orford KeithDirectorSell(S)52K$0.84$44K
Nov 8, 2021Sjogren EricSR. VP, DRUG DISCOVERYTax withholding(F)16K$0.87$14K
Nov 8, 2021Wong StephanieSee RemarksTax withholding(F)16K$0.87$14K
Nov 8, 2021Kuriakose EmilCHIEF MEDICAL OFFICERTax withholding(F)3K$0.87$3K
Nov 8, 2021Parlati FrancescoSR. VP, RESEARCHTax withholding(F)16K$0.87$14K
Nov 5, 2021Orford KeithDirectorGrant(A)30K—$0
Nov 5, 2021Molineaux ChristopherSR. VP, DEVELOPMENTGrant(A)12K—$0
Nov 5, 2021Sjogren EricSR. VP, DRUG DISCOVERYGrant(A)30K—$0
Nov 5, 2021Wong StephanieSee RemarksGrant(A)30K—$0
Nov 5, 2021Ray SumitaSee RemarksGrant(A)12K—$0
Nov 5, 2021Kuriakose EmilCHIEF MEDICAL OFFICERGrant(A)12K—$0
Nov 5, 2021Parlati FrancescoSR. VP, RESEARCHGrant(A)30K—$0
Oct 28, 2021Sjogren EricSR. VP, DRUG DISCOVERYTax withholding(F)46K$1.89$87K
Oct 28, 2021Wong StephanieSee RemarksTax withholding(F)46K$1.89$87K
Oct 28, 2021Parlati FrancescoSR. VP, RESEARCHTax withholding(F)46K$1.89$87K
Oct 27, 2021Sjogren EricSR. VP, DRUG DISCOVERYGrant(A)90K—$0
Oct 27, 2021Orford KeithCHIEF MEDICAL OFFICERGrant(A)90K—$0
Oct 27, 2021Molineaux ChristopherSR. VP, DEVELOPMENTGrant(A)36K—$0
Oct 27, 2021Wong StephanieSee RemarksGrant(A)90K—$0
Oct 27, 2021Ray SumitaSee RemarksGrant(A)36K—$0
Oct 27, 2021Parlati FrancescoSR. VP, RESEARCHGrant(A)90K—$0
Jun 11, 2021Wise BlakeDirectorGrant(A)20K—$0
Jun 11, 2021Wolff Henry WardDirectorGrant(A)20K—$0
Jun 11, 2021Drachman Jonathan GDirectorGrant(A)20K—$0
Jun 11, 2021Pakianathan DeepikaDirectorGrant(A)20K—$0
Jun 11, 2021Garland J. ScottDirectorGrant(A)20K—$0
Jun 11, 2021Jones SuzyDirectorGrant(A)20K—$0
Jun 11, 2021Agarwal SunilDirectorGrant(A)20K—$0
Jun 11, 2021George JeanDirectorGrant(A)20K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).